Compare NUAI & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUAI | CGC |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Pharmaceuticals and Biotechnology |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 403.6M | 467.3M |
| IPO Year | 2024 | 2023 |
| Metric | NUAI | CGC |
|---|---|---|
| Price | $4.84 | $1.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 5.5M | 3.7M |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.89 | ★ 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | $885,400.00 | ★ $12,759,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $15.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 66.18 | N/A |
| 52 Week Low | $0.32 | $0.84 |
| 52 Week High | $9.45 | $2.38 |
| Indicator | NUAI | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 65.75 |
| Support Level | $4.13 | $1.01 |
| Resistance Level | $5.31 | $1.08 |
| Average True Range (ATR) | 0.50 | 0.04 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 15.00 | 90.91 |
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.